Vaxart
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $15,185 | $4,933 | $6,401 | $2,181 |
Gross Profit | 15,185 | 4,933 | -11,079 | 1,081 |
EBITDA | -8,649 | -12,331 | -14,043 | -21,893 |
EBIT | -10,885 | -14,555 | -16,256 | -22,993 |
Net Income | -11,985 | -14,080 | -16,466 | -24,417 |
Net Change In Cash | 15,185 | 4,933 | 6,401 | 2,181 |
Free Cash Flow | -7,389 | -4,210 | -12,397 | -21,322 |
Cash | 25,229 | 22,035 | 43,285 | 26,735 |
Basic Shares | 2,021,375 | 2,274,528 | 1,847,030 | 1,688,110 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $28,700 | $7,379 | $107 | $892 |
Gross Profit | 28,700 | -60,763 | -3,160 | -47,857 |
EBITDA | -54,869 | -72,133 | -103,119 | -66,451 |
EBIT | -63,719 | -80,757 | -106,386 | -68,883 |
Net Income | -66,948 | -82,465 | -107,758 | -70,470 |
Net Change In Cash | 28,700 | 7,379 | 107 | 892 |
Cost of Revenue | -97,732 | 16,875 | ||
Free Cash Flow | -45,318 | -72,324 | -104,380 | -64,989 |
Cash | 25,229 | 34,755 | 44,013 | 143,745 |
Basic Shares | 2,021,375 | 1,448,197 | 1,276,838 | 1,214,537 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.05 |
2024-09-30 | -$0.06 |
2024-06-30 | -$0.09 |
2024-03-31 | -$0.14 |
